Copper IUDs, infection and infertility

Drug and Therapeutics Bulletin

Volumn 40, Issue 9, 2002, Pages 67-69

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COPPER INTRAUTERINE DEVICE; ORAL CONTRACEPTIVE AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECTOPIC PREGNANCY; FEMALE; FEMALE INFERTILITY; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPY; PELVIC INFLAMMATORY DISEASE; PREGNANCY RATE; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE TUBE OCCLUSION;

EID: 0036739666     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2002.40967     Document Type: Article

References (28)

1. Rowland S, Hampton N. Intrauterine contraception. In: Kubba et al (Eds). Contraception and office gynecology. Choices in reproductive healthcare. London: Harcourt Publishers Ltd, 1999.
2. Christian CD. Maternal deaths associated with an intrauterine device. Am J Obstet Gynecol 1974; 119: 441-4.
3. Thomas AK. Septic abortion associated with a Lippes loop. BMJ 1975; 3: 747-8.
4. Sparks RA and Letchworth AT. Mid-trimester septic abortion and Escherichia coli septicaemia in a copper IUCD user. BMJ 1978; 1: 481-2.
5. Smith PA et al. Deaths associated with intrauterine contraceptive devices in the United Kingdom between 1973 and 1983. BMJ 1983; 287: 1537-8.
6. Mann SN et al. Pelvic inflammatory disease. Int J STD AIDS 1996; 7: 315-21.
7. Ross J. Pelvic inflammatory disease. In: Clinical Evidence, Issue 7, June 2002. London: BMJ Publishing Group.
8. Washington AE et al. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991; 266: 2581-6.
9. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000; 356: 1013-9.
10. Kessel E. Pelvic inflammatory disease with intrauterine device use: a reassessment. Fertil Steril 1989; 51: 1-11.
11. Weström L. Incidence, prevalence and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138: 880-92.
12. Wolner-Hanssen P. et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990; 263: 54-9.
13. Guillebaud J. Intrauterine devices and infertility. Lancet 2001; 358: 1460 [letter].
14. Vessey MP et al. Pelvic inflammatory disease and the intrauterine device: findings in a large cohort study. BMJ 1981; 282: 855-7.
15. Buchan H et al. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use. Br J Obstet Gynaecol 1990; 97: 780-8.
16. Farley TMM et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339: 785-8.
17. Potts DM et al. IUDs and PID: a comparative trial of strings versus stringless devices. Adv Contracept 1991; 7: 231-40.
18. Shih S et al. Comparative clinical experience with 3 IUDs, TCu 380 Ag, TCu 220C and Mahua ring, in Tianjin, People's Republic of China. Contraception 1984; 29: 229-39.
19. Cramer DW et al. Tubal infertility and the intrauterine device. N Engl J Med 1985; 312: 941-7.
20. Daling JR et al. Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med 1985; 312: 937-41.
21. Hubacher D. et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med 2001; 345: 561-7.
22. Vessey MP et al. Fertility after stopping use of intrauterine contraceptive device. BMJ 1983; 286: 106.
23. Doll H et al. Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception. Br J Obstet Gynaecol 2001; 108: 304-14.
24. Grimes DA. Intrauterine devices and infertility: sifting through the evidence. Lancet 2001; 358: 6-7.
25. Wilson JC. A prospective New Zealand study of fertility after removal of copper intrauterine devices for conception and because of complications: a four-year study. Am J Obstet Gynecol 1989; 160: 391-6.
26. Skjeldestad F, Bratt H. Fertility after complicated and non-complicated use of IUDs: a controlled prospective study. Adv Contracept 1988; 4: 179-84.
27. Matthews P. Sexual history taking in primary care. In: Carter Y et al (Eds). RCGP handbook of sexual health in primary care. London: Royal College of General Practitioners, 1998.
28. Grimes DA, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion (Cochrane Review). In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software (Last substantive amendment 8 December 2000).